- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
VCs fund new cardiac system
Inovise Medical, a privately held cardiac diagnostic company, has raised $12.5 million in new capital to support development of technology that combines electrical and sound information to evaluate cardiac conditions associated
Inovise Medical, a privately held cardiac diagnostic company, has raised $12.5 million in new capital to support development of technology that combines electrical and sound information to evaluate cardiac conditions associated with coronary artery disease, left ventricular hypertrophy, acute coronary syndrome, and heart failure. This latest round of financing, which was led by new investors MDS Capital and TAT Capital Partners, brings the total equity investment in the firm to $22 million. The company could release its first product later this year. Managers from Hewlett-Packard founded Inovise Medical in 1997.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.
